Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Corrigendum] MicroRNA‑1929‑3p participates in murine cytomegalovirus‑induced hypertensive vascular remodeling through Ednra/NLRP3 inflammasome activation. | Int J Mol Med | 2022 | 35014675 | PubTator, text mining | PubMed |
| Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR. | Cell Death Dis | 2022 | 35013118 | PubTator, text mining | PubMed |
| Lithium and Erectile Dysfunction: An Overview. | Cells | 2022 | 35011733 | PubTator, text mining | PubMed |
| Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer. | Gynecol Oncol Rep | 2022 | 35005155 | PubTator, text mining | PubMed |
| MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH). | BMC Endocr Disord | 2022 | 34986816 | PubTator, text mining | PubMed |
| Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-β receptor. | Mol Cell Biochem | 2022 | 34982346 | PubTator, text mining | PubMed |
| Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity. | Adipocyte | 2022 | 34964707 | PubTator, text mining | PubMed |
| Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. | Thromb Res | 2022 | 34922160 | PubTator, text mining | PubMed |
| Will ETA-antibody arouse new interest in cancer therapeutics? | Trends Pharmacol Sci | 2022 | 34895946 | PubTator, text mining | PubMed |
| Twenty-Five Novel Loci for Carotid Intima-Media Thickness: A Genome-Wide Association Study in >45 000 Individuals and Meta-Analysis of >100 000 Individuals. | Arterioscler Thromb Vasc Biol | 2022 | 34852643 | PubTator, text mining | PubMed |
| Studies on the Vitrified and Cryomilled Bosentan. | Mol Pharm | 2022 | 34851124 | PubTator, text mining | PubMed |
| CD38 plays an age-related role in cholinergic deregulation of airway smooth muscle contractility. | J Allergy Clin Immunol | 2022 | 34800431 | PubTator, text mining | PubMed |
| The role of endothelin II type A receptor (ETAR) in transplant injury. | Transpl Immunol | 2022 | 34793957 | PubTator, text mining | PubMed |
| VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling. | Circ Res | 2022 | 34789016 | PubTator, text mining | PubMed |
| Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors. | Acta Cardiol | 2022 | 34783301 | PubTator, text mining | PubMed |
| Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis. | Adv Med Sci | 2022 | 34781174 | PubTator, text mining | PubMed |
| Left atrial unloading with an 8 mm septal cutting balloon to treat postcapillary pulmonary hypertension: a case report. | ESC Heart Fail | 2022 | 34766440 | PubTator, text mining | PubMed |
| Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via β2-arrestin link to mTOR pathway. | Kidney Int | 2022 | 34757123 | PubTator, text mining | PubMed |
| New locus underlying auriculocondylar syndrome (ARCND): 430 kb duplication involving TWIST1 regulatory elements. | J Med Genet | 2022 | 34750192 | PubTator, text mining | PubMed |
| Whole-Genome Sequencing Association Analyses of Stroke and Its Subtypes in Ancestrally Diverse Populations From Trans-Omics for Precision Medicine Project. | Stroke | 2022 | 34727735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=44